LORA-PITA IV General Investigation

Pfizer

Status: Completed

Conditions: Status Epilepticus

Treatments: Drug: Lorazepam

Study type: Observational

Funder types: Industry

Identifiers

NCT03905798

NCT03905798 (Registry Identifier)

B3541003

Details and patient eligibility

About

Secondary Data Collection:To confirm the effectiveness and safety profiles under the actual medical practice of LORA-PITA in Japan.

Full description

To confirm the effectiveness and safety profiles under the actual medical practice of LORA-PITA for Status Epilepticus patients in Japan.

Enrollment: 206 patients

Sex: All

Ages: 3+ months old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Patients administered Lorazepam in accordance with the indication (for Status Epilepticus) and have no history of using this drug.

Trial design

206 participants in 1 patient group

Lorazepam

Description:

Patients administered Lorazepam in accordance with the indication (for Status Epilepticus, SE) and have no history of using this drug

Treatment:

Drug: Lorazepam